Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas

Cancer Research

Volumn 61, Issue 1, 2001, Pages 45-49

  Musso, Orlando ^a   Rehn, Marko ^b   Théret, Nathalie ^a   Turlin, Bruno ^c   Bioulac Sage, Paulette ^d   Lotrian, Dominique ^a   Campion, Jean Pierre ^a   Pihlajaniemi, Taina ^b   Clément, Bruno ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITY OF OULU   (Finland)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; COLLAGEN; COLLAGEN TYPE 18; ENDOSTATIN; RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; CORRELATION FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TISSUE SPECIFICITY; TUMOR VOLUME;

ALTERNATIVE SPLICING; CARCINOMA, HEPATOCELLULAR; COLLAGEN; COLLAGEN TYPE XVIII; DISEASE PROGRESSION; ENDOSTATINS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; RNA, MESSENGER;

EID: 0035132924     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
2. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
3. The generation of endostatin is mediated by elastase
4. Secreted cathepsin L generates endostatin from collagen XVIII
5. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin
6. Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts
7. The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans
8. Collagen XVIII is localized in sinusoids and basement membrane zones and expressed by hepatocytes and activated stellate cells in fibrotic human liver
9. The promoter of the long variant of collagen XVIII, the precursor of endostatin, contains liver-specific regulatory elements
10. Pathology techniques and grading systems in the diagnosis of HCC
11. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: Its clinical and prognostic significance
12. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver
13. Assessing matrix metalloproteinase expression and activity in hepatocellular carcinomas
14. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers
15. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
16. Tumor development under angiogenic signaling: A dynamical theory of tumor growth, treatment response, and postvascular dormancy
17. Transection of the oesophagus for bleeding oesophageal varices
18. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer
19. Hepatocytes as a source of collagen type XVIII endostatin
20. Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients
21. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma
22. Quantitation of α-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma
23. Assessment of the biological malignancy of hepatocellular carcinoma: Relationship to clinicopathological factors and prognosis
24. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase
25. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
26. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin
27. Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells
28. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis